Funding for Faculty

Additional Details

RFP Snapshot: The Siteman Cancer Center (SCC) Biostatistics and Qualitative Research Shared Resource (BQSR) fulfills a critical function by providing methodologic and analytic support for the development and conduct of scientifically sound, innovative cancer research at SCC. Advances in biotechnologies and computing systems/software increasingly require specialized expertise and tools for sophisticated statistical methodologies. Qualitative research requires sound methods and approaches that support rigor and best practice. The overarching goal of the BQSR is to provide a comprehensive, centralized, and accessible biostatistics and qualitative support infrastructure for all phases of cancer research; from study development and design to data collection, ongoing monitoring, and final analysis.

Max Amount and Period: N/A

Eligibility: Must be a Siteman Cancer Center member.

Due Date: Rolling

Additional Details

RFP Snapshot: The WUSTL Center for Drug Discovery offer the CDD Match Grant15 and Grant25 programs.

Match Grant15 is to advance translational small-molecule drug discovery research at Washington University. CDD offers a full suite of preclinical drug discovery services and know-how. Capabilities range from drug lead finding utilizing the High Throughput Screening Core to Medicinal Chemistry-driven drug lead optimization, ADME profiling, and in vivopharmacokinetics for proof-of-concept in vivo pharmacology studies, intellectual property (patent) filing, and drug development.

Match Grant25 is a follow-on award program meant only for those investigators who have successfully completed and met the objectives of a Match Grant15 (or the original CDD MicroGrant) award and request additional match funds to further advance the discovery research project. CDD offers a full suite of preclinical drug discovery services and know-how. Capabilities range from drug lead finding utilizing the High Throughput Screening Core to Medicinal Chemistry-driven drug lead optimization, ADME profiling, and in vivo pharmacokinetics for proof-of-concept in vivo pharmacology studies, intellectual property (patent) filing, and drug development.

Max Amount and Period:

Match Grant15 – $7,500 from CDD

Match Grant25 – $12,000 from CDD

Eligibility:

Match Grant15 – open to investigators with a faculty appointment at Washington University

Match Grant25 – open only to WashU faculty who have successfully completed a Match Grant15 (or CDD MicroGrant) and submitted a final research report.

Due Date: Rolling

Additional Details

RFP Snapshot: The purpose of the awards is to advance initial discovery pilots for Precision Health ICTS investigators. Proposals are not for developed projects but are to fund developmental or early stage work, including pilot data collection and analysis, in preparation for submission of future external funding.

Max Amount and Period: $25,000 for 1 year

Eligibility: Applicants must be full time faculty (instructor level or above) at Washington University in St. Louis or an ICTS partner institution. Applicant must be a member of the ICTS.

Due Date: Rolling

Additional Details

RFP Snapshot: The Just-In-Time (JIT) Core Usage Funding Program is designed to provide quick access to funding to use any of the JIT Cores (pdf) for research advancing medical knowledge that can improve human health. Siteman Cancer Center will co-sponsor cancer-focused proposals.

Max Amount and Period: Varies

Eligibility: Applicant must be a registered member of the ICTS and hold a faculty level appointment at WUSTL or an ICTS partner institution.

Due Date: Rolling

Additional Details

RFP Snapshot: There is a special emphasis on projects that accelerate existing preclinical and clinical research that increases therapeutic options, improves adjuvant therapies, delivers novel therapies focused on driver mutations (BRAF, TP53, KRAS, BRCA1, as examples) and investigate strategies to influence the tumor microenvironment (TME) to expand the use of immunotherapy. See RFA for other eligible research objective priorities.

Max Amount and Period: $200,000 over 2 years

Eligibility: Applications will be accepted from non-profit, for-profit, and academic organizations, and from investigators who hold MD, PhD, or other professional degrees.

Due Date: Rolling

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Pioneering Ideas: Exploring the Future to Build a Culture of Health welcomes proposals that are primed to influence health equity in the future. We seek ideas that address any of RWJF’s Pioneering Ideas for an Equitable Future team’s four current areas of focus described below: 1) Future of Evidence; 2) Future of Social Interaction; 3) Future of Food; and 4) Future of Work. Additionally, under Open Exploration, also described below, this call for proposals seeks ideas that might fall outside of these four focus areas but which offer unique approaches to advancing health equity and our progress toward a Culture of Health.

Max Amount and Period: No limit for 3 years, but budget must be reasonably supported by scope of project.

Eligibility: Applicant organizations must be based in the US or its territories. Preference will be given to applicant organizations that are either institutes of higher education, public entities, or nonprofits that are tax exempt under Section 501(c)(3) of the Internal Revenue Code.

Due Date: Rolling

Additional Details

RFP Snapshot: This multi-investigator grant is designed to support a coordinated, focused, and significant effort to understand the biology of follicular lymphoma and develop effective treatments for the disease. A team comprised of multiple investigators from the same or different institutions working collaboratively will be required for this grant. A major emphasis in the STA is on clinical translation of scientific results. Ideally, a STA application will propose a combination of basic and translational laboratory research that will lead to eventual clinical translation.

Max Amount and Period: $6.5M over 5 years

Eligibility: Applicants must hold a PhD, MD, DVM, or equivalent degree and must be affiliated with a non-profit Institution at the time funding commences and for the duration of the award. Applications may involve multiple institutions.

Due Date: Letter of Intent Due: September 9, 2024 at 2pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: These grants aim to support clinical and/or biological research. Activities supported by these awards should lead to initiation of a clinical trial by year three of the grant.

Max Amount and Period: $1.75M over 5 years

Eligibility: Applicants must hold a PhD, MD, DVM, or equivalent degree and must be affiliated with a non-profit institution at the time funding commences and for the duration of the award. Applications may involve multiple institutions.

Due Date: Letter of Intent Due: September 9, 2024 at 2pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The purpose of the Catalyst Award opportunity is to catalyze the research of early-stage investigators with high-scoring, but unfunded research projects recently submitted to either the American Cancer Society – Research Scholar Grant or the National Cancer Institute – R01 grant funding mechanisms. Through the Catalyst Awards, ACS intends to sustain the projects and investigators as they continue to apply for research grants, including resubmissions of their unfunded proposals.

IMPORTANT: Eligible applicants MUST contact Doug Hurst, PhD at ACS for the application materials. Email: [email protected]

Max Amount and Period: $150,000 for 1 year

Eligibility: Applicants must have a doctoral degree and have an independent faculty appointment. Additionally, applicants MUST either a) have applied for an ACS Research Scholar Grant April 2023-April 2024 and received a score of Outstanding following review, but the application was unfunded, OR b) must have have applied for an NIH R01 to the NCI in 2023 or 2024 and scored in the 20th percentile or better, but missed the payline cutoff.

Due Date: September 9, 2024

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The objective of this AGA Research Foundation Pilot Research Award is to provide funds to early career investigators to help establish their research careers or to support projects that represent new research directions for established investigators.

Max Amount and Period: $40,000 for 1 year

Eligibility: Applicants must hold MD, PhD, and/or equivalent and a full-time faculty position. AGA membership is required at the time of submission. Applicants who are physician scientists, female, or from racial/ethnic groups underrepresented in biomedical research are strongly encouraged to apply.

Due Date: September 12, 2024

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The objective of this AGA Research Foundation award is to support an established investigator in the field of gastric cancer research working to enhance our fundamental understanding of gastric cancer pathobiology or approaches to prevent, treat or cure gastric cancer.

Max Amount and Period: $100,000 for 1 year

Eligibility: Applicants for this award must hold an MD, PhD and/or equivalent degree (e.g., MBBS, MBChB, DO) and be established investigators with full-time faculty positions. MD applicants are considered “established” if 7 or more years have elapsed following the completion of their clinical training at the start date of this award (April 2025). PhD applicants are considered “established” if seven or more years have elapsed following the awarding of the PhD degree and the start date of this award. AGA membership is required at the time of application submission.

Due Date: September 12, 2024

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The objective of this AGA Research Foundation award is to provide supplemental funding to early career investigators who have existing career development awards and are conducting research relevant to the pathogenesis, prevention, diagnosis or treatment of digestive cancer.

Max Amount and Period: $40,000 for 1 year

Eligibility: Candidates for this award must hold an MD, PhD and/or equivalent degree (e.g., MB, ChB, MBBS, DO) and have an “early career” full-time faculty position. Applicants must hold an NIH K series (e.g. K01, K08, K23, K99, R00) or other federal or non-federal career development award of at least 4 years duration. There must be at least one year remaining on the award on April 1, 2025. Applicants may NOT hold an R01 or equivalent. MD applicants are considered “early career” if no more than 7 years have elapsed following the completion of clinical training at the start date of this award (i.e., April 2025). PhD applicants are considered “early career” if no more than 7 years have elapsed following the awarding of the PhD degree and the start date of this award. AGA membership is required at the time of application submission.

Due Date: September 12, 2024

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This funding opportunity is part of LLS’s Equity in Access Research Program, designed to generate evidence that will guide changes in healthcare policy and practice to ensure that all patients with and survivors of a blood cancer have the ability to access and utilize optimal treatment, care, and resources that can improve their quality of life and outcomes, from diagnosis through survivorship. This opportunity seeks to fund proposals that will implement and evaluate interventions designed to a) mitigate barriers to therapeutic clinical trial accrual for underrepresented groups, and b) quantitatively measure the impact of these interventions on patient accrual. LLS will support research that will guide changes in evidence-based practice and policy. LLS is particularly interested in proposals that address systemic, institutional, and/or clinician-related barriers that impede clinical trial participation.

Max Amount and Period: $2.5M over 2 years

Eligibility: LLS welcomes PIs at all stages of their careers as well as PIs who have not previously conducted research in the area of blood cancer. However, if the Principal Investigator is an early investigator, a more experienced Co-Principal Investigator is required. The PI must have a PhD, MD, DO, ScD, JD, or equivalent doctoral degree. Multi-disciplinary teams are strongly encouraged.

Due Date: Letter of Intent Due: September 12, 2024 at 2PM CST

Pre-Application Webinar: Be sure to register for the upcoming pre-app webinar on June 18, 2024 from 11am to noon CST here: https://tlls.zoom.us/webinar/register/WN__kqRZkR0RDKSr2HeBYjmAg#/registration

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Rally funds pediatric cancer research in the following areas:
• Innovative approaches to research which could lead to advanced studies or clinical trials.
• Basic science studies that are likely to lead to a new discovery.
• Personalized, targeted, alternative or integrative research proposals.
• Under-studied cancer types.
• Quality of life, survivorship and palliative care studies.
• Data utilization through data standardization, collection, storage, analysis and sharing.

Max Amount and Period: $100,000 over 2 years

Eligibility: All academic ranks, Instructor to Professor, and research scientists with MD, DO, PharmD, and/or PhD degrees may apply. Researchers under this award identify as either a Young Investigator or an Independent Investigator. Young Investigators are no more than five years post fellowship (as of July 1, 2025). Applicants need not be U.S. citizens.

Due Date: Letter of Intent Due: September 13, 2024 at 2:30PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Rally funds pediatric cancer research in the following areas:
• Innovative approaches to research which could lead to advanced studies or clinical trials.
• Basic science studies that are likely to lead to a new discovery.
• Personalized, targeted, alternative or integrative research proposals.
• Under-studied cancer types.
• Quality of life, survivorship and palliative care studies.
• Data utilization through data standardization, collection, storage, analysis and sharing.

Max Amount and Period: $200,000 over 2 years

Eligibility: All academic ranks, Instructor to Professor, and research scientists with MD, DO, PHarmD, and/or PhD degrees may apply. Consortiums are three or more institutions collaborating on a grant-supported research project. Applicants need not be U.S. citizens.

Due Date: Letter of Intent Due: September 13, 2024 at 2:30PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Collaborative invites applications for innovative research strategies that directly address pediatric, adolescent or young adult cancers through a novel idea built around one of the Focus Areas outlined in Section II of the RFA. These grants are designed to provide seed funding for a new idea that may not have preliminary data but for which a strong case can be made for the potential impact for children, adolescents and young adults battling cancer.

Max Amount and Period: $50,000 for 1 year

Eligibility: Fellows conducting pediatric cancer research as clinical fellows in pediatric hematology/oncology and/or postdoctoral research fellows. The grant is available for MD, DO, PharmD or PhD fellows after the first year of their fellowship. All academic ranks, Instructor to Professor, and research scientists with MD, DO, PharmD and/or PhD degrees, no more than five years post fellowship. At the end of the award, researchers may apply for additional funding in the next grant cycle through a Fellow, Independent Investigator or Consortium Grant, as appropriate. Applicants need not be U.S. citizens.

Due Date: Letter of Intent Due: September 13, 2024 at 2:30PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This grant is open to all gynecologic cancers. The Foundation gratefully acknowledges all participants and supporters of this year’s Move4Her campaign for making this grant possible.

Max Amount and Period: $50,000 for 1 year

Eligibility: Priority will be given to young investigators. Young investigators are people who have not been funded by the Department of Defense, the American Cancer Society, or the National Cancer Institute in this area of research. SGO members who apply should be junior investigators, generally Assistant Professors & below (within 7 years of first faculty appointment). Others are open to apply but priority will be given to junior investigators. Full professors are not allowed to apply. Non-Society of Gynecologic Oncology (SGO) members may apply with a co-investigator who is an SGO member. Document this relationship in the application. Non-SGO members may also apply if they have an SGO member sponsor them. The SGO member does not need to be involved in the research.

Due Date: Letter of Intent Due: September 15, 2024 at 11:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The National Ovarian Cancer Coalition (NOCC) supports their mission to save lives through the prevention and cure of ovarian cancer in part by donating to ovarian cancer research.

Max Amount and Period: $50,000 for 1 year

Eligibility: Priority will be given to young investigators. Young investigators are people who have not been funded by the Department of Defense, the American Cancer Society, or the National Cancer Institute in this area of research. SGO members who apply should be junior investigators, generally Assistant Professors & below (within 7 years of first faculty appointment). Others are open to apply but priority will be given to junior investigators. Full professors are not allowed to apply. Non-Society of Gynecologic Oncology (SGO) members may apply with a co-investigator who is an SGO member. Document this relationship in the application. Non-SGO members may also apply if they have an SGO member sponsor them. The SGO member does not need to be involved in the research.

Due Date: Letter of Intent Due: September 15, 2024 at 11:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This grant is related to all gynecologic cancers except ovarian cancer. No fetal tissue may be used when conducting this research.

Max Amount and Period: $50,000 for 1 year

Eligibility: Priority will be given to young investigators. Young investigators are people who have not been funded by the Department of Defense, the American Cancer Society, or the National Cancer Institute in this area of research. SGO members who apply should be junior investigators, generally Assistant Professors & below (within 7 years of first faculty appointment). Others are open to apply but priority will be given to junior investigators. Full professors are not allowed to apply. Non-Society of Gynecologic Oncology (SGO) members may apply with a co-investigator who is an SGO member. Document this relationship in the application. Non-SGO members may also apply if they have an SGO member sponsor them. The SGO member does not need to be involved in the research.

Due Date: Letter of Intent Due: September 15, 2024 at 11:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The National Ovarian Cancer Coalition (NOCC) also puts forth their fourth grant through the FWC focused on Quality of Life in relation to ovarian cancer. NOCC is making this funding available as part of their commitment to investing in meaningful research that serves the ovarian cancer community.

Max Amount and Period: $50,000 for 1 year

Eligibility: Priority will be given to young investigators. Young investigators are people who have not been funded by the Department of Defense, the American Cancer Society, or the National Cancer Institute in this area of research. SGO members who apply should be junior investigators, generally Assistant Professors & below (within 7 years of first faculty appointment). Others are open to apply but priority will be given to junior investigators. Full professors are not allowed to apply. Non-Society of Gynecologic Oncology (SGO) members may apply with a co-investigator who is an SGO member. Document this relationship in the application. Non-SGO members may also apply if they have an SGO member sponsor them. The SGO member does not need to be involved in the research.

Due Date: Letter of Intent Due: September 15, 2024 at 11:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This grant is related to all gynecologic cancers. The Foundation gratefully acknowledges all SGO members who contributed to this grant during the 2024 SGO Winter Meeting. This is the first research grant funded through SGO member donations during the SGO Winter Meeting.

Max Amount and Period: $25,000 for 1 year

Eligibility: Priority will be given to young investigators. Young investigators are people who have not been funded by the Department of Defense, the American Cancer Society, or the National Cancer Institute in this area of research. SGO members who apply should be junior investigators, generally Assistant Professors & below (within 7 years of first faculty appointment). Others are open to apply but priority will be given to junior investigators. Full professors are not allowed to apply. Non-Society of Gynecologic Oncology (SGO) members may apply with a co-investigator who is an SGO member. Document this relationship in the application. Non-SGO members may also apply if they have an SGO member sponsor them. The SGO member does not need to be involved in the research.

Due Date: Letter of Intent Due: September 15, 2024 at 11:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: St. Louis Ovarian Cancer Awareness (SLOCA) is committed to impacting ovarian cancer survivorship by promoting awareness of early warning signs and standards of care, funding ovarian cancer research, & supporting survivors.

Max Amount and Period: $37,500 for 1 year

Eligibility: Priority will be given to young investigators. Young investigators are people who have not been funded by the Department of Defense, the American Cancer Society, or the National Cancer Institute in this area of research. SGO members who apply should be junior investigators, generally Assistant Professors & below (within 7 years of first faculty appointment). Others are open to apply but priority will be given to junior investigators. Full professors are not allowed to apply. Non-Society of Gynecologic Oncology (SGO) members may apply with a co-investigator who is an SGO member. Document this relationship in the application. Non-SGO members may also apply if they have an SGO member sponsor them. The SGO member does not need to be involved in the research.

Due Date: Letter of Intent Due: September 15, 2024 at 11:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This grant supports research focused on the intersection of diversity and cervical cancer research. Proposals should seek to eliminate inequities in cervical cancer care, specifically related to differential outcomes experienced by people from underserved or marginalized populations with cervical cancer, and to increase representation of underrepresented groups in the cervical cancer community as a strategy to achieve health equity for underserved people. This is the second grant supported by the Harold and Barbara Rosenbaum Family Foundation. The Foundation gratefully acknowledges the Harold and Barbara Rosenbaum Family Foundation for their support of this grant.

Max Amount and Period: $55,350 for 1 year

Eligibility: Applicants must be from a race, ethnicity, gender identity, or sexual orientation historically underrepresented in cancer research OR their proposal must address gynecologic cancer topics among populations who are underserved or marginalized, based on their race, ethnicity, gender identity, sexual orientation, or socioeconomic status including, but not limited to: access to care, therapeutic trials, and survivorship issues. Priority will be given to young investigators. Young investigators are people who have not been funded by the Department of Defense, the American Cancer Society, or the National Cancer Institute in this area of research. SGO members who apply should be junior investigators, generally Assistant Professors & below (within 7 years of first faculty appointment). Others are open to apply but priority will be given to junior investigators. Full professors are not allowed to apply. Non-Society of Gynecologic Oncology (SGO) members may apply with a co-investigator who is an SGO member. Document this relationship in the application. Non-SGO members may also apply if they have an SGO member sponsor them. The SGO member does not need to be involved in the research.

Due Date: Letter of Intent Due: September 15, 2024 at 11:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This grant is intended to honor both Wilma Williams and the tireless work and dedication of all gynecologic oncologists, and to ensure the ability to pass on and preserve the specialized medical skills and tools to those physicians who will carry the torch.

Max Amount and Period: $25,000 for 1 year

Eligibility: Priority will be given to young investigators. Young investigators are people who have not been funded by the Department of Defense, the American Cancer Society, or the National Cancer Institute in this area of research. SGO members who apply should be junior investigators, generally Assistant Professors & below (within 7 years of first faculty appointment). Others are open to apply but priority will be given to junior investigators. Full professors are not allowed to apply. Non-Society of Gynecologic Oncology (SGO) members may apply with a co-investigator who is an SGO member. Document this relationship in the application. Non-SGO members may also apply if they have an SGO member sponsor them. The SGO member does not need to be involved in the research.

Due Date: Letter of Intent Due: September 15, 2024 at 11:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The LLS Discovery Grant Program is a research award program designed to encourage basic research, technological innovation, and informatics pipeline development. Also known as the Blood Cancer Discoveries Grant Program, DGP hopes to gain better understanding of blood cancer disease mechanisms, to help develop improved methods for detecting and monitoring cancer progression, and to help identify novel therapeutic targets.

Max Amount and Period: $25,000 for 1 year

Eligibility: This opportunity is for established independent academic investigators for support of foundational, discovery-stage research that can lead to advances in the treatment and cure of blood cancers. Applicants need not be US citizens. Applicants must hold a PhD, MD, DVM, or equivalent degree.

Due Date: Letter of Intent Due: September 18, 2024 at 2PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This funding opportunity provides research funding to early-career investigators to encourage and promote quality research in global oncology and to develop the next generation researchers to address global health needs. Global oncology research generally applies the concepts of global health to cancer, and implies an approach to the practice of oncology that acknowledges the reality of limited resources in most parts of the world.

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants must have a doctoral degree (MD, PhD, MD/PhD, DO, or equivalent) and be in the last year of training OR during the first two years of a faculty/staff appointment at the time of submission and within 10 years of terminal degree. Applicants must be an ASCO member or submitted an application for membership. Must be able to commit at least 60% of full-time effort to research. There are no citizenship requirements, so long as the visa status will provide sufficient time to complete the project.

Due Date: Letter of Intent Due: September 19, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This funding opportunity provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this award is to fund physicians during the transition from a fellowship program to a faculty appointment. This is a mentored award and the research project is conducted under the guidance of an experienced mentor in the proposed research area. Applications in all areas of cancer research are accepted from U.S. and international applicants. Dedicated funds exist for the following special emphases:
• Equity in Genomics
• Health Disparities Research
• Diversity, Inclusion, and Health Equity
• Women Who Conquer Cancer YIA

Max Amount and Period: $50,000 for 1 year

Eligibility: Applicants must be physicians (MD, DO, or equivalent) and be in the last two years of subspeciality training AND within 10 years of terminal degree. MD/PhDs are eligible if both degrees are completed prior to start of grant. Applicants must have a mentor from the sponsoring institution. Applicants must be an ASCO member or submitted an application for membership. Must be able to commit at least 60% of full-time effort to research. There are no citizenship requirements, so long as the visa status will provide sufficient time to complete the project.

Due Date: September 19, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The program will match early-stage researchers who wish to develop a successful research career with more experienced NRG Oncology investigators who are capable and willing to serve as mentors. Selecting underrepresented minority fellows and mentors is the main goal for the program. We are interested in studies where investigators are developing protocols that focus on health equity. Having both attributes is the priority, but not a requirement for selection.

Max Amount and Period: $50,000 over 2 years

Eligibility:
• Medical, surgical, gynecologic, or radiation oncologists or PhD prepared researchers who have completed fellowship/postdoc training.
• Applicants must NOT have been a PI or co-PI on a clinical trial/NIH R level grant within the past 10 years.
• Must have previous experience within NRG Oncology or make a future commitment to do so.
• Must have institutional support, at least 10% FTE dedicated to this program.
• Priority will be given to individuals from underrepresented populations as defined by NIH.

Due Date: September 20, 2024

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Team Science Awards are designed to foster a collaborative research process and promote transformational melanoma research advances with the potential for rapid clinical translation. Evidence of prior collaboration among team members is encouraged, but not required. For the 2024-2025 review cycle, Team Science proposals will ONLY be accepted for the two special opportunities announced in this RFP: Pediatric Melanoma or Neoadjuvant Translational Research.

Max Amount and Period: $900,000 over 3 years

Eligibility: The team must be multidisciplinary, and consist of two or more established Principal Investigators, one of whom is designated the Administrative PI, a Young Investigator with complementary expertise, and a Mentor for the Young Investigator; Teams may consist of investigators from the same institution, or different institutions, and may be international; All other Principal
Investigators on the team share authority for scientific leadership; The Administrative PI and any other Principal Investigators on the team must be senior investigators, past the initial five years of their first academic faculty appointment and must hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above. See RFA for full eligibility details.

Due Date: Letter of Intent Due: September 27, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Academic-Industry Partnership (AIP) Award (for Teams) is designed to enhance translational research by extending academic capabilities to clinical investigations and to facilitate interactions between the academic and industrial research sectors.

Max Amount and Period: $900,000 over 3 years

Eligibility: The team must be multidisciplinary, and consist of two or more established Principal Investigators, one of whom is designated the Administrative PI, a Young Investigator with complementary expertise, and a Mentor for the Young Investigator; Teams may consist of investigators from the same institution, or different institutions, and may be international; All other Principal
Investigators on the team share authority for scientific leadership; The Administrative PI and any other Principal Investigators on the team must be senior investigators, past the initial five years of their first academic faculty appointment and must hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above. See RFA for full eligibility details.

Due Date: Letter of Intent Due: September 27, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The International Development and Education Award (IDEA) provides support for early-career oncologists in developing countries and facilitates the sharing of knowledge between these oncologists and ASCO members. The program pairs IDEA Recipients with a leading ASCO member Mentor, and enables recipients to attend the ASCO Annual Meeting, participate in a post-Meeting visit to their Mentor’s institution, and develop long-term relationships to improve cancer care in their countries and inform ASCO programs in developing countries. In addition, a special focus award exists under this mechanism specific to palliative care. An ASCO member in the U.S. or Canada who volunteers to serve as a mentor and is matched to an IDEA Recipient based on shared professional and scientific interests.

Max Amount and Period: Various necessary travel, lodging, membership, and conference expenses

Eligibility: Applicants must be a current resident of a country classified by the World Bank as Low-Income, Lower-Middle-Income, or Upper-Middle-Income, and have limited resources to attend the ASCO Annual Meeting. Applicants should be within ten years of graduating from their oncology program training, fluent in English, and cannot have completed more than one academic year of formal training. See RFA for more details.

Due Date: September 30, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: To increase participation of Black men with prostate cancer in clinical trials, ACS is announcing a new grant opportunity to support local oncology practices and hospitals in their efforts to expand clinical trial enrollment. This opportunity is part of the ACS IMPACT (Improving Mortality from Prostate Cancer Together) initiative. ACS will facilitate the use of Trial Library, a platform that helps clinical oncology practices identify clinical trials, pre-screen patients, and provides technology-enabled navigation services to ensure patients have needed resources to enroll and complete trials.

Max Amount and Period: $400,000 over 2 years

Eligibility: Eligible applicants must have direct patient interaction and the capability to participate in clinical trials. Because this initiative aims to expand past established networks, groups affiliated with an NCI-designated comprehensive cancer center must clearly justify how this award would engage community practices and diversify trial enrollment.

Due Date: Letter of Intent Due: September 30, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The purpose of this Notice of Funding Opportunity (NOFO) is to support collaborative research focused on understanding the long-term effects of natural and/or human-made disasters on healthcare systems serving populations that experience health disparities living in the U.S. and its territories.

Max Amount and Period: Budget should reflect needs. 5 year project period.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support.

Due Date: October 5, 2024 at 5PM CST

Additional Details

RFP Snapshot: This initiative will support multi-level and/or multi-domain intervention research to reduce disparities in liver diseases and liver cancer among populations who experience health disparities in the United States (U.S.).

Max Amount and Period: Budget should reflect needs. 5 year project period.

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support.

Due Date: October 5, 2024 at 5PM CST

Additional Details

RFP Snapshot: The purpose of this initiative is to support research to develop and test community-level interventions to improve minority health and reduce health disparities.

Max Amount and Period: $5M over 5 years

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support.

Due Date: October 5, 2024 at 5PM CST

Additional Details

RFP Snapshot: Seeking applications to test innovative approaches to implementing SBIRT/P for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities. SBIRT/P, (a term used for purposes of this funding announcement), involves screening individuals for risk of ATOD use and misuse, briefly intervening with a conversation about harmful substance use, and referring individuals for treatment or preventive services, as needed.

Max Amount and Period: Budget should reflect needs. Over 5 years

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support.

Due Date: October 5, 2024 at 5PM CST

Additional Details

RFP Snapshot: This RFA is seeking translational and preclinical projects that focus on addressing areas of high unmet need and are designed to lead to clinical studies of therapies for children within a three-year timeframe. While all applications addressing unmet needs in pediatric oncology are welcome, this solicitation includes a Notice of Special Interest for projects specifically aimed at developing therapies for neuroblastoma. Applicants are encouraged to detail how their proposal will address critical challenges and overcome significant barriers in pediatric oncology treatment.
Max Amount and Period: $1.5M over 3 years

Eligibility: The applicant must be the principal investigator (PI). The PI must be an independent investigator at any level who is affiliated with an academic institution. Applications are open to applicants in North America, the European Union, Japan, the United Kingdom, China, and Australia. Non-U.S. applicants must comply with U.S. anti-terrorism financing laws. The applicant must have a doctoral degree, including MD, PhD, DO, or equivalent. Laboratory scientists and clinical investigators must have adequate space to conduct proposed research and protected time for research, verified by a Letter of Institutional Support. For applicants seeking support of $500,000 or greater, a minimum committed effort of 10% from the PI is required. Applicants must not hold an active CureSearch grant or apply for funding through another CureSearch program during the same cycle.

Due Date: Letter of Intent Due: October 7, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The CAMS award provides support to facilitate the transition from mentored position to independence for the early career physician scientists. The program is ideal for the physician scientist considering an academic career. Proposals must be in the area of basic biomedical, disease-oriented, or translational research. Proposals that incorporate artificial intelligence and machine learning or climate change and human health are of particular interest.

Max Amount and Period: $700,000 over 5 years

Eligibility: Candidates must hold an MD, DDS, DVM, VMD, or DO degree and have completed clinical training (residency or fellowship), and be board eligible by the award start date. Candidates may hold a junior faculty appointment (Lecturer, Instructor, Assistant Professor-non-tenure track, etc.). At the time of application, candidates cannot hold nor have accepted, either in writing or verbally, a faculty appointment as a tenure track Assistant Professor. Citizens and non-citizen permanent and temporary residents of the U.S. and Canada who are legally qualified to work in the U.S. or Canada are eligible. Candidates who are temporary U.S. residents must hold a valid U.S. visa (J-1, H1B, F-1 or O-1 visas). Applicants must be able to devote at least 75% of their time to total research activities.

BWF strongly encourages applications from persons who have been historically underrepresented in the research enterprise, including but not limited to: women of any ethnic or racial group; any person identifying as Black or African American, Latino/a or Hispanic American, Native American, Alaska Native, Native Hawaiian, indigenous to the Pacific Islands, indigenous Canadian; persons with disabilities; persons from disadvantaged backgrounds (see https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-031.html for examples). BWF also strongly encourages individuals who identify as LGBTQIA+ to apply. There are many training paths that can prepare candidates for a career as a physician scientist, and BWF seeks to ensure that CAMS awardees reflect this. Therefore, special consideration will be given to single degree physician-scientists (M.D., D.O., D.V.M., V.M.D., D.D.S.) as well as dual degree physician-scientists who have not historically been well represented in our applicant or awardee pool (D.V.M., Ph.D., D.O., Ph.D., D.D.S., Ph.D., M.D., M.S., M.D., M.P.H., etc).

Due Date: October 8, 2024 at 2PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This Award represents a joint effort to encourage and support early career scientists engaged in pancreatic cancer research relevant to the goals and mission of the Lustgarten Foundation. The proposed project may be basic, translational, clinical, or population sciences related research and must have direct applicability and relevance to the understanding, detection, diagnosis, or treatment of pancreatic cancer. Applications are invited from researchers currently in the field as well as investigators with experience in other areas of cancer or biomedical research who have promising ideas and approaches that can be applied to pancreatic cancer research.

Max Amount and Period: $300,000 over 3 years

Eligibility: The intent of this program is to support the development and diversity of talent working in pancreatic cancer research. Eligibility is limited to members of racial or ethnic groups that have been shown to be underrepresented in the cancer related sciences workforce. Selection is competitive and will be based on outstanding accomplishments in scientific research. Applicants must be investigators with a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently a candidate for a further doctoral degree. At the start of the grant term on July 1, 2025, applicants must hold the rank of Assistant Professor and have independent laboratory space. There are no citizenship requirements. All applicants must be AACR Active members in good standing.

Due Date: October 10, 2024 at Noon CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This Award is intended to support investigators who have received their initial faculty appointment to establish an independent bladder cancer (including upper tract disease) research program and successful career path. The research proposed for funding may be translational, clinical (including clinical trials), or epidemiological, must have direct applicability and relevance to bladder cancer and/or upper tract urothelial cancer, and must demonstrate the likelihood of translating new concepts into clinical practice. Project proposals should have measurable outcomes during the three-year grant period and include research milestones for the conclusion of the grant.

Max Amount and Period: $250,000 over 3 years

Eligibility: At the time of submission, the applicant must have a doctoral degree (e.g., MD, DO, DDS, Ph.D., DNP, DSW, PharmD, PsyD, DVM, or equivalent) in the biomedical sciences or a field applicable to health science research and may not currently be a candidate for a further doctoral degree. The applicant must be an assistant professor, instructor, research assistant professor, or equivalent within seven years of their first full-time faculty appointment. At the time of application submission, the applicant cannot hold the associate or full professor title. The applicant must be from a US or Canadian sponsoring academic, nonprofit, or governmental institution. Proof of permanent resident status or a valid work visa is required if the applicant is not an American or Canadian citizen.

Due Date: October 11, 2024 at 4PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Discovery Boost Grants (DBG) support high-risk, high-reward exploratory cancer research across the research continuum. Investigators may focus on developing research methodologies, establishing feasibility, or leading pilot tests. It is expected that preliminary data generated from a completed DBG will have the potential to secure additional grant funding to further the research and open new and highly innovative areas for investigation.

Max Amount and Period: $270,000 over 2 years

Eligibility: PIs must have an independent faculty appointment at a US academic institution.

Due Date: October 15, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Clinician Scientist Development Grant (CSDG) supports full-time faculty members in becoming independent investigators as clinician scientists. This grant is designed for people trained primarily as clinicians who want to maintain clinical practice and conduct cancer research.

Max Amount and Period: $405,000 to $675,000 over 3-5 years

Eligibility: Applicants must have a doctoral degree, an active clinical license, and participate in clinical care. They must not be a current or former PI of an individual mentored training grant. They also must not have had an R-level or equivalent grant as PI.

Due Date: October 15, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Clinician Scientist Development Grant (CSDG) supports full-time faculty members in becoming independent investigators as clinician scientists in radiation oncology. This grant is designed for people trained primarily as clinicians who want to maintain clinical practice and conduct cancer research.

Max Amount and Period: $405,000 to $675,000 over 3-5 years

Eligibility: Applicants must have a doctoral degree, an active clinical license, and participate in clinical care. They must not be a current or former PI of an individual mentored training grant. They also must not have had an R-level or equivalent grant as PI.

Due Date: October 15, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: STAGE 1 requires the investigator to develop outcome-specific, unequivocal milestones that reduce the risks of studying a new drug, device, or procedure in patients.

Mission Boost Grants (MBG) are designed to support select current and past ACS grantees specifically for the translation of their research to human testing. MBGs are opportunities for American Cancer Society (ACS) grantees to seek additional, or “boost,” resources for innovative, high-risk/high-reward projects.

Max Amount and Period: $270,000 over 2 years

Eligibility: PIs must have an independent faculty appointment at a US academic institution and have held or currently hold one of the following ACS grants for a minimum 1 year:

• Research Scholar Grant (RSG)
• Clinician Scientist Development Grant (CSDG)
• Mentored Research Scholar Grant (MRSG)
• Cancer Control Career Development Award (CCCDA)
• Pilot and Exploratory Projects in Palliative Care (PEP) Award
• ACS Postdoctoral Fellowship (previous fellows only)
• Discovery Boost Grant (DBG)

Due Date: October 15, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: STAGE 2 supports testing in cancer patients.

Mission Boost Grants (MBG) are designed to support select current and past ACS grantees specifically for the translation of their research to human testing. MBGs are opportunities for American Cancer Society (ACS) grantees to seek additional, or “boost,” resources for innovative, high-risk/high-reward projects.

Max Amount and Period: $545,000 over 18 months

Eligibility: PIs must have an independent faculty appointment at a US academic institution and have held or currently hold a Stage 1 Mission Boost Grant for a minimum of 18 months AND have completed Stage 1 milestones.

Due Date: October 15, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Research Scholar Grants (RSG) provide support for independent, self-directed researchers and clinician scientists, who are investigators licensed to provide patient care and trained to conduct research. Grant proposals are investigator-initiated and may pursue questions across the cancer research continuum, as long as they fit within an American Cancer Society (ACS) priority research area.

Max Amount and Period: $860,000 over 4 years

Eligibility: PIs must work at a US academic institution and have been appointed as an independent, full-time faculty LESS than 10 years ago. Additionally, they may not be the PI on more than one R01 or equivalent grant at the time of application.

Due Date: October 15, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: To address the public health burden of prostate cancer, ACS has launched the IMPACT Initiative – Improving Mortality from Prostate CAncer Together. To bolster our strategic research efforts, ACS will fund research projects focused on reducing prostate cancer mortality and improving outcomes for all. Priority will be given to applications with direct relevance to reducing health disparities in prostate cancer mortality.

Max Amount and Period: Varies based on mechanism:
• Research Scholar Grant: $860,000 over 4 years
• Clinician Scientist Development Grant: $405,000 to $675,000 over 3 to 5 years
• Discovery Boost Grant: $270,000 over 2 years
• Postdoc Fellowship: $209,500 over 3 years

Eligibility: See RFAs of the specific mechanism for eligibility guidelines.

Due Date: October 15, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The TRP Grant program is geared towards translational medicine for blood cancers. Earlier work in the translational environment has been funded in the past through the TRP mechanism, however, these types of projects would be a better fit for our Discovery Grant Program and applicants are directed to apply under that mechanism. For the 2025 application cycle we will only consider applications that adhere to the following submission guidelines:
• For small molecule compounds the application must have in vivo proof of concept (POC) in appropriate mouse models. Alternatively, based on the mechanism of action, an in vitro POC with patient-derived samples may be considered.
• For cellular or immunotherapies, in vivo POC would make for a stronger application. We acknowledge, however, that depending on the type of therapy being developed an in vitro POC may be more appropriate or necessary.

Max Amount and Period: $750,000 over 3 years

Eligibility: Applicant must be an established, independent investigator, defined as a researcher with more than 3 years in an independent faculty appointment.

Due Date: Letter of Intent Due: October 16, 2024 at 2PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) intends to accelerate the development of evidence-based cancer-related interventions that reflect the diversity of people, places, contexts, and settings in the United States. Specifically, this FOA will support research that tests the impact of cancer-related interventions on cancer-related outcomes across the cancer control continuum using a pragmatic trial study design. This FOA will use the UG3/UH3 phased cooperative agreement mechanism. The UG3 phase will support refining the cancer-related intervention and finalizing study-related activities in preparation for conducting the pragmatic trial during the UH3 phase.

Max Amount and Period: $4M over 6 years

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support.

Due Date: October 17, 2024 at 5PM CST

Additional Details

RFP Snapshot: The Conquer Cancer Career Development Award (CDA) provides funding to clinical investigators who have received their initial faculty appointment and are establishing an independent clinical cancer research program. This is a mentored award and the research project is conducted under the guidance of an experienced mentor in the proposed research area. Applications in all areas of cancer research are accepted from U.S. and international applicants.

Max Amount and Period: $200,000 over 3 years

Eligibility: Be a physician (MD, DO, or equivalent) working in any country. Must be in the first to fourth year of a full-time faculty appointment in a clinical department. Must have completed productive postdoctoral research and demonstrated the ability to undertake independent investigator-initiated clinical research. Must be an ASCO member or have submitted a membership application. Be able to commit at least 50% of their time to total research. Must have a mentor. Provided there are no scientific or budgetary overlaps, it is okay to apply with other federal career development awards (K23, K09, etc.) or training grants (T32, KL2/K12, etc), although the applicant may not hold another career development award from a private foundation. Applicant also cannot be the PI on any large project grants.

Due Date: October 17, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Conquer Cancer Career Development Award (CDA) provides funding to clinical investigators who have received their initial faculty appointment and are establishing an independent clinical cancer research program focused on palliative and supportive care. This is a mentored award and the research project is conducted under the guidance of an experienced mentor in the proposed research area. Applications in all areas of cancer research are accepted from U.S. and international applicants.

Max Amount and Period: $200,000 over 3 years

Eligibility: Be a physician (MD, DO, or equivalent) working in any country. Must be in the first to fourth year of a full-time faculty appointment in a clinical department. Must have completed productive postdoctoral research and demonstrated the ability to undertake independent investigator-initiated clinical research in palliative and supportive care. Must be an ASCO member or have submitted a membership application. Be able to commit at least 50% of their time to total research. Must have a mentor. Provided there are no scientific or budgetary overlaps, it is okay to apply with other federal career development awards (K23, K09, etc.) or training grants (T32, KL2/K12, etc), although the applicant may not hold another career development award from a private foundation. Applicant also cannot be the PI on any large project grants.

Due Date: October 17, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Leukemia & Lymphoma Society supports talented blood cancer researchers in the early phase of their careers through the Career Development Program. CDP continues to provide a pool of dedicated researchers to advance the understanding and diagnosis of blood cancer, as well as the development of treatment and prevention options that will ultimately lead to a higher quality of life for blood cancer patients.

Max Amount and Period: Varies based on mechanism:
• Scholar in Clinical Research:
$625,000 over 5 years
• Scholar Grant:
$600,000 over 5 years
• Special Fellow Grant:
$225,000 over 3 years
• Fellow Grant:
$210,000 over 3 years

Eligibility: See RFAs of the specific mechanism for eligibility guidelines.

Due Date: Eligibility Deadline: October 18, 2024 at 2PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Model Continuums of Care Initiative will apply the latest dissemination and implementation science approaches to significantly reduce the prevalence and impact of multi-morbidity among racial/ethnic minority women and girls of reproductive age at risk and living with mental health disorders, substance use disorders, chronic stress, cardiopulmonary diseases, common metabolic disorders (e.g., diabetes), cancer, and HIV/AIDS. Special emphasis will be placed on using stakeholder partnerships, provider training, and infrastructure changes to improve access for subgroups of racial/ethnic minority women and girls who currently have the least access to high quality health care (e.g., racial/ethnic minority women and girls living in low resource settings).

Max Amount and Period: $600,000 over 3 years

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support.

Due Date: October 18, 2024 at 5PM CST

Additional Details

RFP Snapshot: The purpose of this notice of funding opportunity (NOFO) is to support developmental/exploratory research to improve health in Native American populations. This includes 1) etiologic research that will directly inform intervention development or adaptations, 2) research that develops, adapts, or tests interventions for health promotion, prevention, treatment, or recovery, and 3) where a sufficient body of knowledge on intervention efficacy exists, research on strategies to overcome barriers to the adoption, integration, scale-up, and sustainability of effective interventions. Through this initiative, culturally appropriate and community-engaged exploratory/developmental research is sought that builds upon Native community knowledge, resources, and resilience to provide foundational knowledge that will inform effective and scalable interventions.

Max Amount and Period: $275,000 over 2 years

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support.

Due Date: October 21, 2024 at 5PM CST

Additional Details

RFP Snapshot: The purpose of this notice of funding opportunity (NOFO) is to support developmental/exploratory research to improve health in Native American populations. This includes 1) etiologic research that will directly inform intervention development or adaptations, 2) research that develops, adapts, or tests interventions for health promotion, prevention, treatment, or recovery, and 3) where a sufficient body of knowledge on intervention efficacy exists, research on strategies to overcome barriers to the adoption, integration, scale-up, and sustainability of effective interventions. Through this initiative, intervention and related research is sought to build upon community knowledge, resources, and resilience to identify and rigorously test culturally appropriate solutions to reduce morbidity and mortality.

Max Amount and Period: $2.5M over 5 years

Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support.

Due Date: October 21, 2024 at 5PM CST

Additional Details

RFP Snapshot: CLL Society is pleased to announce a funding opportunity for researchers who are early in their careers, have not yet established themselves as independent researchers, and plan on
having a career in the field of CLL/SLL and related disorders such as Richter’s transformation. The Young Investigator Award is intended to develop medical knowledge, thereby stimulating
future research that is applicable to the development of medical innovations that will save and sustain the lives of those with CLL and SLL. Basic bench and translational research projects in all areas of CLL and SLL are eligible for this proposal. Emphasis will be placed on the innovation and transformative potential of submitted proposals. Proposals must contain a laboratory research-based component to be eligible for this award. Projects that have a clinical research component will be considered, but clinical research should not be the main component of the proposal.

Max Amount and Period: $150,000 over 3 years

Eligibility: The Young Investigator is defined as a junior faculty member (instructor or assistant professor) and/or postdoctoral fellow whose focus is on pre-clinical research. Applicants should ideally be fellows or scientists with an MD, DO, and/or PhD from an accredited institution who plan to be tenure-tracked (or are already tenured) by the time the grant term begins.

Due Date: Letter of Intent Due: October 21, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: CLL Society is pleased to announce a funding opportunity for scientists who are specifically interested in researching how integrative medicine approaches might improve the lives
of those living with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). The Integrative Medicine Award is intended to support exceptionally innovative research projects that aim to provide an understanding of the mechanistic basis or clinical outcomes related to the use of integrative therapies, specifically for those living with CLL and SLL. The award aims to encourage exploration of research ideas that incorporate an integrative approach to addressing the many health challenges of those living with the disease, help to address gaps in current research, and build a strong evidence base to improve quality of life.

Max Amount and Period: $200,000 over 2 years

Eligibility: See RFA.

Due Date: Letter of Intent Due: October 21, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: CLL Society is pleased to announce a funding opportunity for exceptional physician researchers who have already established themselves in the field of CLL/SLL. This Award is
designed to support the research efforts of an advanced physician scientist who is engaged in independent clinical research and has demonstrated exceptional leadership, scholarship, and academic success. The Clinical Scholar Award is intended to advance the development of treatment and/or preventative options that lead to a higher quality of life for those living with CLL and SLL, while
continuing to support the careers of established physician scientists.

Max Amount and Period: $300,000 over 3 years

Eligibility: Clinical scholar must be a MD, DO, or equivalent and an independent clinician investigator who is mid-stage in their career with a strong focus on CLL research and/or treatment. Mid-stage independent clinician investigators are defined by CLL Society’s Research Program as being someone who is within five years or less of acquiring a full professor position (or the equivalent) as of the funding start date of the Clinical Scholar Award on July 1st, 2025. The applicant must currently spend 30% or more of their time on basic, translational, or clinical research efforts in their current position, but still have direct patient contact and clinical responsibilities in their role.

Due Date: Letter of Intent Due: October 21, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Young Investigator Awards aim to attract early career faculty with original ideas into the field of melanoma, thereby recruiting and supporting the next generation of melanoma research leaders. Awardees will be provided funding to accomplish innovative and original, preclinical, translational, and/or early clinical research projects. Young Investigators are scientists within the first five years of their first academic faculty appointment. A mentorship commitment from a senior investigator is required.

Max Amount and Period: $255,000 over 3 years

Eligibility: Applicants must be within the first five years of their first independent, full time academic faculty appointment at the application deadline, at the level of Assistant Professor (or equivalent position); Applicants must designate at least one Mentor who is an established investigator at the same institution who will ensure that adequate support and guidance are provided for successful
completion of the proposed research project and provide career mentorship. At least one Mentor with expertise in melanoma research is strongly advised. See RFA for more details.

Due Date: Eligibility Checklist Due: October 21, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This is a special opportunity to support research in radiation oncology to improve treatment options for melanoma patients. Early career radiation oncologists, radiation or cancer
biologists, or physicists are encouraged to submit radiation oncology Research Proposals that include at least 50% effort on melanoma.

Max Amount and Period: $255,000 over 3 years

Eligibility: See RFA for Young Investigator Awards for eligibility requirements. In addition, the applicant must be a member in good standing of ASTRO at the time of award activation.

Due Date: Eligibility Checklist Due: October 21, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Grant proposals should be investigator-initiated and pursue questions specifically designed to enable the discovery of cancer interception or prevention therapies for RUNX1-FPD HMs. LEAP-Research Scholar Grants support an independent research project that aligns with one of the two LEAP program focus areas. Research Scholar Grants (RSGs) provide support for independent, self-directed researchers. LEAP-Team Awards support a team research project that aligns with one of the LEAP program research focus areas. The application must clearly articulate how the team will synergize to accelerate scientific advancement and clinical benefit.

Max Amount and Period:

LEAP-Research Scholar Grant: $860,000 over 4 years

LEAP-Team Award: $1,720,000 over 4 years

Eligibility: See RFA for details.

Due Date: October 29, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The primary objective of proposed Phase I/II or Phase II clinical trials in relapsed/refractory osteosarcoma should be to improve event free survival (EFS) at 4 months beyond historical rates known to be in the range of 12% for patients with unresectable disease. The proposed trial may be carried out in a single institution, a clinical trial consortium, or through an existing clinical trial infrastructure.

Max Amount and Period: $800,000 over 2-3 years

Eligibility: The applicant’s history of efficiently entering agreements, opening trials, and meeting accrual expectations for trials of relapsed osteosarcoma patients, with the expectation that results will be available within three years of trial initiation.

Due Date: Letter of Intent: October 31, 2024 at 3PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Correlative studies should seek to generate data from clinical trials aimed at improving event free survival of recurrent and metastatic osteosarcoma patients. Our highest priorities for correlative science proposals are to create the opportunity, should the associated clinical trial fail, to understand the reasons for that failure and allow for productive iteration of the approach; and 2) to identify specific predictors of response.

Max Amount and Period: $200,000 – $500,000 over 2 years

Eligibility: See RFA

Due Date: Letter of Intent: October 31, 2024 at 3PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: A translational imperative for the OSI is to cultivate and support a research agenda that will identify biological dependencies in the disease that can be targeted in patients. This research agenda will ideally include the use of novel laboratory approaches and bioinformatic tools applied to osteosarcoma cells, a diversity of in vivo models across species and human patient samples. Furthermore, we are particularly interested in the study of dependencies that may impact a variety of potential phenotypes associated with the disease, including metastatic proclivity, DDR
in the context of a structurally complex genome, identifying novel disease targets using surfaceome approaches, targeting mechanisms of resistance to first generation T cell checkpoint blockade in osteosarcoma, and other immunotherapeutic opportunities.

Max Amount and Period: $500,000 over 2 years

Eligibility: See RFA.

Due Date: Letter of Intent: October 31, 2024 at 3PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The aim of this grant program is to place less emphasis on preliminary data in order to encourage projects exploring bold innovations that may fall within any stage of the drug development path, and that seek to deliver curative outcomes to patients with osteosarcoma. Proposals will be most valued based on their innovation and sound scientific hypothesis, and the likelihood that the approach will address a true dependency in osteosarcoma.

Max Amount and Period: $25,000 to $125,000 for 1 year

Eligibility: See RFA.

Due Date: Letter of Intent: October 31, 2024 at 3PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This funding is geared toward studies about “upstream” causes of health inequities, such as the systems, structures, laws, policies, norms, and practices that determine the distribution of resources and opportunities, which in turn influence individuals’ options and behaviors. Research should center on the needs and experiences of communities exhibiting the greatest health burdens and be motivated by real-world priorities. It should be able to inform a specific course of action and/or establish beneficial practices, not stop at characterizing or documenting the extent of a problem.

Max Amount and Period: No limit for 3 years, but budget must be reasonably supported by scope of project.

Eligibility: Applicant organizations must be based in the US or its territories. Preference will be given to applicant organizations that are either institutes of higher education, public entities, or nonprofits that are tax exempt under Section 501(c)(3) of the Internal Revenue Code.

Due Date: Letter of Intent Due: November 1, 2024 at 1pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Research Specialist Award (Lab Scientist) is intended to provide salary support for a sustained period of time and encourage the development of a stable career for exceptional researchers who want to pursue particular research activities within the context of a research program, but not be independent investigators. These scientists, such as researchers within a research program, are vital to sustaining the biomedical research enterprise. The award is intended for laboratory research-oriented investigators with significant, relevant experience, who have shown clear evidence of productivity and research excellence in the field of their training and would like to support a particular research activity (e.g., a research program), with the goal of making significant contributions to behavioral, biomedical (basic or clinical), computational, bioimaging or bioengineering research that is relevant to the NCI mission. The proposed new research support is intended to provide salaries and sufficient autonomy so that individuals are not solely dependent on NCI-funded grants held by others for career continuity.

Max Amount and Period: Salary support for the Research Specialist commensurate with their level of funded effort (not less than 6 person-months) on NCI-funded research grants

Eligibility: The Research Specialist must be the PD/PI of the application. The Unit Director must not be the PD/PI. However, the Unit Director must be included as Senior/Key Personnel participating as an Other Significant Contributor.

Due Date: November 1, 2024 at 5pm CST

Additional Details

RFP Snapshot: The Research Specialist Award (Core-based Scientist) is intended to provide salary support for a sustained period of time and encourage the development of a stable career for exceptional researchers who want to continue to support cancer research within the context of a core/shared resource/central scientific support. These scientists, namely researchers within a core/shared resource/central scientific support, are vital to sustaining the biomedical research enterprise.The award is intended for research-oriented investigators with significant, relevant experience, who have shown clear evidence of productivity and research excellence in the field of their training, and who would like to support a particular research activity (e.g., core/shared resource/central scientific support), with the goal of making significant contributions to behavioral, biomedical (basic or clinical), computational, bioimaging or bioengineering research that is relevant to the NCI mission. The proposed new research support is intended to provide salaries and sufficient autonomy so that individuals are not solely dependent on NCI-funded grants held by others for career continuity.

Max Amount and Period: Salary support for the Research Specialist commensurate with their level of funded effort (not less than 6 person-months) on NCI-funded research grants

Eligibility: The Research Specialist must be the PD/PI of the application. The Unit Director must not be the PD/PI. However, the Unit Director must be included as Senior/Key Personnel participating as an Other Significant Contributor.

Due Date: November 1, 2024 at 5pm CST

Additional Details

RFP Snapshot: The RFA is for pre-clinical or translational work for gastroesophageal cancer that will lead to a clinical trial within two years. This is to accelerate drug development and to bring new therapies to patients as quickly as possible. Up to two grants will be awarded with a completion date of two years. Grants may be supported in full or partially based on the aims of the project, novelty and feasibility.

Max Amount and Period: $500,000 over 2 years

Eligibility: Applicants must have a faculty appointment. No citizenship requirements. Interdisciplinary collaborations are encourages and independent investigators at all career stages are encouraged to apply.

Due Date: November 1, 2024 at 10:59pm CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Established Investigator Awards support senior investigators with an established record of scientific productivity and accomplishment.

Max Amount and Period: $375,000 over 3 years

Eligibility: Applicants must be a senior investigator, past the initial five years of their first academic faculty appointment. Applicants must hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above.

Due Date: November 4, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: The Academic-Industry Partnership (AIP) Award (for Established Investigators) is designed to enhance translational research by extending academic capabilities to clinical  investigations and to facilitate interactions between the academic and industrial research sectors. These awards will be co-funded by MRA and an industry partner whose involvement is essential to the project.

Max Amount and Period: $375,000 over 3 years

Eligibility: Applicants must be a senior investigator, past the initial five years of their first academic faculty appointment. Applicants must hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above. Applicants must identify an industry partner at the time of application.

Due Date: November 4, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: Pilot Awards support senior investigators who propose potentially transformative ideas that do not have extensive preliminary data but articulate a clear hypothesis and translational goals. Resources for such “high-risk, high-reward” projects are important to establish proof-of-concept, which may then leverage additional funding through more traditional avenues.

Max Amount and Period: $100,000 over 2 years

Eligibility: Applicants must be a senior investigator, past the initial five years of their first academic faculty appointment. Applicants must hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above.

Due Date: November 4, 2024 at 10:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: RWJF Health Policy Fellows program seeks outstanding midcareer health professionals, behavioral and social scientists, and others with an interest in health and the drivers of health who (1) possess the skills and commitment to use the fellowship experience to provide leadership in improving health and the drivers of health through policy change at the national, state, or local level; (2) bring a depth of expertise and knowledge about health, health equity, and the drivers of health to the policymaking process; and (3) can offer an informed perspective on important and complex challenges facing policymakers.

Max Amount and Period: $175,000 over 1-2 years

Eligibility: Applicants must be exceptional midcareer professionals who have earned their doctoral degree and have deep experience and subject matter expertise in a discipline that affects health. Individual candidates for receipt of award funds must be U.S. citizens or permanent residents at the time of application.

Due Date: November 5, 2024 at 2PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Optional Webinar: Optional applicant webinars are being held on 9/6, 9/18, 10/9, and 10/24. Register here: https://healthpolicyfellows.org/

Additional Details

RFP Snapshot: This award is meant to address the gap between technology development and clinical application of cancer immunotherapies. These grants aim to encourage collaboration between technology developers and clinical cancer immunologists and to generate the proof-of-principle of a novel platform technology in bioinformatics, ex vivo or in silico modeling systems, immunological or tumor profiling instrumentation, methods, reagents and assays, or other relevant technologies that can enable clinician scientists to generate deeper insights into the mechanisms of action of effective or ineffective cancer immunotherapies.

Max Amount and Period: $200,000 over 2 years

Eligibility: Applicants must hold a faculty appointment as a tenure-track Assistant Professor (or higher rank) at the time of award activation. If applicants have prospective faculty appointments, documentation from their institution must accompany the Letter of Intent indicating they will hold the position of Assistant Professor (or higher rank) by the time of award activation.The grant will be awarded to a scientist who describes an extraordinarily novel, yet practical research plan that is creative and technically sophisticated.

Due Date: Letter of Intent Due: November 15, 2024 at 4PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This grant is intended to provide financial support to promising young researchers to advance the understanding of complications and therapeutic strategies in the context of hematological diseases. The research proposal needs to address issues on hematopoietic stem cell transplantation or cell therapy for hematological diseases. Various aspects can be covered, including but not limited to: diagnostic and therapeutic strategies, transplant immunology, stem cell transplantation complications, donor selection, or cell manufacturing.

Max Amount and Period: €240,000 over 3 years

Eligibility: Applicants must have received a doctoral degree (PhD, MD, or equivalent achievements) in a field pertinent to the grant within the last 10 years from the grant call start date (for details please refer to the funding guidelines). Applicants do not need to hold a faculty position and may be trainees (Fellows, Postdoctoral Fellows, and Junior Faculties). Applicants from all countries are invited to submit an application.

Due Date: November 20, 2024 at 4:59PM CST

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.

Additional Details

RFP Snapshot: This RFP welcomes clinical trials focused on therapy optimization in all types of pediatric blood cancers, such as new combination therapy, reduction of chemotherapy by integrating immunotherapy, and reduction in intensity or duration of maintenance therapy. We encourage interventional clinical trials (Phase I, II, or III) that include measurements of biomarkers to drive treatment decision-making and to assess the impact of an intervention (e.g., minimal residual disease). This should help to correlate optimization or de-escalation of treatment while maintaining efficacy. Additionally, interventional clinical trials that focus on novel, less-toxic, targeted agents and immunotherapies, which might improve outcomes and decrease toxicity compared to current regimens, will also be considered.

Max Amount and Period: Amount TBD, up to 5 years

Eligibility: Clinical trials are eligible if they meet all the following criteria:

Due Date: Letter of Intent Due: November 22, 2024

Application Assistance: Washington University faculty may reach out to Glenn Floyd in Medical Corporate and Foundation Relations at [email protected] with any questions and for assistance with reviewing/editing your proposal.